A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

The stem cell-based therapy has emerged as the promising therapeutic strategies for
cardiovascular diseases (CVDs). Recently, increasing evidence suggest stem cell-derived …

Rationale: Mesenchymal stromal cell–based therapy is promising against ischemic heart
failure. However, its efficacy is limited due to low cell retention and poor paracrine function …

Cardiovascular diseases (CVDs) remain a major health concern worldwide, where
mesenchymal stem cells (MSCs) therapy gives great promise in their management through …

Cardiovascular diseases (CVDs) are pointed out by the World Health Organization (WHO)
as the leading cause of death, contributing to a significant and growing global health and …

Ischemic diseases are conditions associated with the restriction or blockage of blood supply
to specific tissues. These conditions can cause moderate to severe complications in …

Systemic sclerosis (SSc) is a rare autoimmune disease, which is potentially lethal. The
physiopathology of the disease is still incompletely elucidated although the role of …

This study was aimed at investigating whether Elabela (ELA) gene therapy can promote
angiogenesis in the treatment of myocardial infarction (MI). The fusion expression plasmid …

Cardiovascular diseases (CVDs) are a major cause of death worldwide. Due to the
prevalence of many side effects and incomplete recovery from pharmacotherapies, stem cell …

In the beginning stage of heart disease, the blockage of blood flow frequently occurs due to
the persistent damage and even death of myocardium. Cicatricial tissue developed after the …